|
May 14
|
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
|
|
Jan 29
|
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™
|
|
Dec 22
|
Longeveron Announces Closing of $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
|
Dec 21
|
UPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
|
Dec 21
|
Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
|
Nov 10
|
Longeveron Reports Third Quarter 2023 Results and Provides Corporate Update
|
|
Nov 10
|
LGVN Continues to Show Progress
|
|
Nov 3
|
Longeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10, 2023
|